Bryan Giles joins CRK from a large, international, pharmaceutical company. His practice involves a combination of patent procurement, freedom-to-operate due diligence, post-grant proceedings, and patent litigation work.
Bryan is one of several attorneys at CRK with both law firm and in-house legal experience. He feels that perspective allows him to better anticipate the needs of his clients. “Having been in the client’s shoes really informs the way I interact with clients,” he notes, “from the way I present information to the way I assist them in setting expectations with their business counterparts.”
Bryan understands that budgets often require clients to direct their legal spend in an manner that is designed to do more than simply maximize patent protection. “For me, it comes down to adherence to an IP strategy that serves a client’s overall commercial objectives,” he says. “Without a plan and an understanding of how IP will advance those objectives, it’s hard for a business to know how and where to invest it’s IP budget in a cost-effective manner, whether it’s protecting internal R&D efforts, acquiring patent assets, or addressing infringement risks from third-party IP.” Bryan’s portfolio development strategies help ensure that a client’s patents provide value to the business. He also reviews patent portfolios for issues pertaining to validity, infringement, and freedom-to-operate. He has also been involved with complex patent litigation issues.
Bryan represents businesses in the fields of medical device, electrical engineering, computer hardware and software, and telecommunications.